角膜内皮移植术后早期玻璃酸钠对泪膜及角膜上皮细胞再生的作用

目的　研究1 g·L^-1和3 g·L^-1玻璃酸钠（hyaluronate，HA）滴眼液对角膜内皮移植术后早期泪膜及角膜上皮细胞再生的作用。方法　选择2017年9月至2018年2月在北京大学第三医院行角膜内皮移植术的患者60例（60眼），随机分成1 g·L^-1HA组和3 g·L^-1HA组，每组各30例，观察标准干眼评估问卷（SPEED）评分、结膜角膜染色评分（OSS）、泪膜破裂时间（TBUT）、角膜上皮缺损范围，进行激光共聚焦显微镜检查。比较不同时间点组间、组内各指标差异。结果　SPEED评分:各时间点两组间比较差异均无统计学意义（均为P>0.05）。组内比较:两组组内术后7 d、14 d、28 d均低于前一时间点（均为P=0.000），余相邻时间点两两比较差异均无统计学意义（均为P>0.05）。TBUT:术后7 d、14 d、28 d 3 g·L^-1HA组均显著高于1 g·L^-1HA组（均为P<0.05），而术前组间差异不显著；组内比较:1 g·L^-1 HA组后一时间点较前一时间点、3 g·L^-1HA组术后7 d较术前均显著延长(均为P<0.05)，而3 g·L^-1HA组术后14 d、28 d与前一时间点差异均无统计学意义（均为P>0.05）。 OSS评分:术前及术后1 d、3 d两组间比较差异均无统计学意义（均为P>0.05），术后7 d、14 d、28 d 3 g·L^-1HA组均显著低于1 g·L^-1HA组（均为P<0.05）；组内比较:两组术后1 d OSS评分均显著高于术前（均为P=0.000），其余时间点两组均低于前一时间点（均为P=0.000）。角膜上皮缺损范围:术后1 d 两组间比较差异均无统计学意义（均为P>0.05），术后3 d、7 d 两组间比较，以及两组组内与前一时间点比较差异均有统计学意义（均为P<0.05）。角膜基底细胞密度:术前、术后28 d两组间比较，以及1 g·L^-1HA组组内术前与术后28 d比较差异均无统计学意义（均为P>0.05），而3 g·L^-1 HA组术后28 d显著低于术前（P=0.002）。结论　HA可以有效改善角膜内皮移植术后早期泪膜状态并促进角膜上皮细胞再生，存在浓度依赖性。     

Examination of the knee for MRCS OSCE

This article is intended as a guide to help improve and perfect your knee examination technique for the MRCS examination. The knee is a joint frequently assessed in the MRCS OSCE, due to the presence of reliable clinical signs in the chronic patient, who can easily attend for repeated examinations. The article will guide the reader through important aspects of the history and physical examination and how these can inform the clinical reasoning process and subsequent diagnosis and management.     

臭氧联合治疗膝关节半月板损伤的临床研究

目的探讨臭氧冲洗联合手法整复治疗膝关节半月板损伤的临床效果。方法选择本院90例膝关节半月板损伤患者作为本次研究对象,病例收集时间为2017年5月-2018年5月。按照治疗分组,手法整复组采取手法整复治疗,臭氧治疗组采用臭氧冲洗治疗,手法整复联合臭氧组则采取手法整复治疗+臭氧冲洗治疗。比较三组疗效;膝关节疼痛缓解的时间、膝关节疼痛消失的时间;治疗前后患者膝关节疼痛VAS评分值以及生活质量QOL评分值;不良作用发生率。结果手法整复联合臭氧组疗效高于手法整复组与臭氧治疗组,P<0.05;手法整复联合臭氧组膝关节疼痛缓解的时间、膝关节疼痛消失的时间优于手法整复组与臭氧治疗组,P<0.05;治疗前三组膝关节疼痛VAS评分值以及生活质量QOL评分值接近,P>0.05;治疗后手法整复联合臭氧组膝关节疼痛VAS评分值以及生活质量QOL评分值优于手法整复组与臭氧治疗组,P<0.05。手法整复联合臭氧组不良作用发生率和手法整复组与臭氧治疗组接近,P>0.05。结论手法整复治疗+臭氧冲洗治疗膝关节半月板损伤的疗效好,可更好改善膝关节疼痛VAS评分值以及生活质量QOL评分值。     

Dry eye signs and symptoms in aromatase inhibitor treatment and the relationship with pain

PurposeAromatase inhibitors (AIs) limit the synthesis of oestrogen in peripheral tissues thus lowering levels of oestrogen. The primary aim was to evaluate whether women treated with AIs have altered dry eye symptoms and signs. A sub-aim was to investigate whether symptoms of dry eye in postmenopausal women were associated with symptoms of non-eye pain, ocular pain and self-rated pain perception.MethodsThis cross-sectional, observational, single visit study recruited 56 postmenopausal women (mean age 64.1 + 7.9 years) and 52 undergoing AI treatment (mean age 66.6 + 9.0). Ocular symptoms (OSDI, MGD14) and pain questionnaires (PSQ, OPAS) were administered and signs of dry eye and meibomian gland dysfunction were evaluated.ResultsAlmost half of each group reported dry eye symptoms, defined as OSDI>12 (48% control, 46% AI). The PSQ score was significantly higher in the AI group (p = 0.04). Neither frequency or severity of dry eye (or MGD) symptoms scores were significantly different between groups. In the AI group, meibomian gland expressibility score was worse (p = 0.003); there were no differences in any other signs. Higher OSDI scores were associated with higher OPAS eye-pain scores (r = 0.49, p < 0.001), but not OPAS non-eye pain (r = 0.09, p = 0.35). Pain perception (PSQ) showed a moderate positive association with OPAS eye-pain (r = 0.30, p = 0.003).ConclusionsIn this study elevated ocular symptoms were observed in both the AI treated and the untreated groups, with no difference between the groups. Women undergoing AI treatment for early stage breast cancer had worse meibum expressibility score and increased pain perception compared to an untreated group of women.     

Is Internal brace augmentation a gold standard treatment compared to isolated Modified Brostrom Gould repair for chronic lateral ligament ankle instability? Effect on functional outcome and Return to preinjury activity: A retrospective analysis

IntroductionModified Brostrom Gould (MBG) repair is widely accepted procedure for chronic lateral ankle instability (CLAI), but there are limitations with regards to strength of repair and risk of reinjury and complications. Internal brace has been recently used as augmentation of standard MBG repair. It provides stronger construct, facilitates early mobilisation and protects repaired ligament with minimal surgical morbidity. The aim of present study is to compare the outcome of MBG repair without and with Internal brace augmentation (IB) in CLAI.MethodsRetrospective analysis of 172 patients with CLAI who underwent MBG repair with or without IBA between November 2017 and October 2019. Patients were evaluated for Visual analogue scale (VAS), Manchester-oxford foot questionnaire (MOxFQ), Patients subjective satisfaction and return to preinjury activity level.Results148 patients were included in the study with 87 in MBG group and 61 in IB group. The mean age, average injury-surgery interval and mean follow up duration was 40.6 ± 11.2 vs 37.5 ± 14.7 years, 13.1 ± 10.3 vs 14.1 ± 8 months and mean follow up duration of 24.2 ± 5.1 vs 20.7 ± 6.0 months respectively (p > 0.05). The mean time to return to preinjury activity level was significantly better in IB group compared to MBG group of 12.1 ± 2.3 vs 20.3 ± 3.9 weeks, p < 0.001. 55 (90.2%) patients in IB and 73 (83.7%) in MBG group return to preinjury activity level. Mean postoperative VAS score (1.9 ± 1.5 vs. 1.7 ± 1.4, p = 0.428), Mean MOxFQ score (19.7 ± 22.2 vs. 18.2 ± 15.4, p = 0.674) showed no significant difference between MBG and IB group respectively, at final follow up.ConclusionThe use of IB augmentation with MBG repair showed significantly better outcome in terms of early rehabilitation and return to preinjury activity level compared to isolated MBG repair. The functional outcome and VAS score were better in IB group compared to MBG group with no significant difference.Level of evidenceLevel IV retrospective study.